Stock Analysis
Hamilton Lane Incorporated (HLNE) Stock Analysis
Hamilton Lane Incorporated (HLNE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Hamilton Lane Incorporated (HLNE) currently has an AIQ Score of 54/100, indicating a neutral setup. Quality is the strongest factor at 85/100. Momentum is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
HLNE at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $95.98 |
| AIQ Score | 54/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $5.72B |
| P/E Ratio | 15.8 |
| Forward P/E | — |
| EPS | $1.94 |
| Revenue TTM | $275.33M |
| Dividend Yield | 0.01% |
| Beta | 1.17 |
| Volume | 558.05K |
| 52-week range | $71.88-$155.66 |
| RSI 14 | 29.28 |
| 50-Day SMA | $94.78 |
| 200-Day SMA | $105.99 |
| Analyst Price Target | $136.44 |
| Next Earnings | Nov 3, 2026 |
HLNE
OverviewHLNE Stock Analysis Summary
Hamilton Lane Incorporated (HLNE) currently has an AIQ Score of 54/100, indicating a neutral setup. Quality is the strongest factor at 85/100. Momentum is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, HLNE has AIQ Score of 54/100 with Quality base of 85/100 and fading Momentum at 32/100. Wait for component alignment before adding exposure.
Quality (85/100) leads while Momentum (32/100) lags. This cross-factor spread creates entry timing uncertainty.
Financial Services · 0.20% stock move · HLNE classified in Asset Management.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is HLNE Bullish or Bearish Right Now?
HLNE currently has a neutral overall setup. Quality is the strongest factor at 85/100, while Momentum is weakest at 32/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 85/100.
- - Risk Resilience is supportive at 64/100.
- - Price is +1.27% above its 50-day SMA.
- - Analyst target implies +42.15% upside from the latest quote.
- - Value is the current constraint at 35/100.
- - Momentum is weak at 32/100.
- - Price is -9.44% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (32 vs 12).
Current Consensus
HLNE's Technical Analysis Consensus is currently Sell, with 12 buy, 1 neutral, and 32 sell votes. HLNE's 14-day RSI is 29.28, which places the stock in an oversold momentum range. HLNE's beta is 1.17, indicating market sensitivity broadly in line with the market.
What Changed in HLNE?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the HLNE Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
HLNE Decision Framework
Public evidence layers, setup checks, and risk context for Hamilton Lane Incorporated.
Hamilton Lane Incorporated (HLNE) Stock Analysis
Hamilton Lane Incorporated has an AIQ Score of 54/100 in a Neutral regime. Quality is strongest at 85/100. Beta is 1.17, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | HLNE is in a Neutral AIQ regime with score 54/100. |
| Signal Conflict | The primary conflict is that quality leads at 85/100 while momentum lags at 32/100. |
| Factor Evidence | Momentum 32/100 · Value 35/100 · Quality 85/100 · Risk 64/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 85/100.
Momentum is 32/100 and RSI (14) is 29.3.
HLNE is in a Neutral regime at 54/100.
Risk factor is 64/100 with beta 1.17 and annual volatility 42.14%.
Current conflict: quality leads at 85/100 while momentum lags at 32/100.
HLNE Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
HLNE Fundamentals
HLNE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
HLNE Technical Analysis
HLNE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
HLNE Stock Catalysts
Track HLNE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
HLNE Dividend Analysis
HLNE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
HLNE Financial Data
HLNE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
HLNE Risk Analysis
HLNE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
HLNE Stock News
HLNE stock news, market tone, recent headlines, and catalyst context.
HLNE vs Asset Management / Exchanges Peers
Current peer cohort: HLNE · HRB · ICE · IDCC · IVZ. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| HLNE Current stock | 54/100 | 35/100 | 32/100 | 64/100 | -0.93 | 42.14% | Current |
| HRB H&R Block | 37/100 | 57/100 | 27/100 | 32/100 | -0.09 | 47.01% | HLNE vs HRB |
| ICE Intercontinental Exchange | 50/100 | 28/100 | 52/100 | 66/100 | -0.39 | 25.10% | HLNE vs ICE |
| IDCC InterDigital | 64/100 | 50/100 | 63/100 | 57/100 | 0.49 | 49.00% | HLNE vs IDCC |
| IVZ Invesco | 56/100 | 50/100 | 63/100 | 52/100 | 1.16 | 34.17% | HLNE vs IVZ |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching HLNE
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for HLNE
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
HLNE Stock FAQ
What is HLNE stock price today?
Hamilton Lane Incorporated's current stock price is $95.98. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is HLNE bullish or bearish right now?
HLNE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is HLNE's market cap?
HLNE's market cap is $5.72B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is HLNE's current P/E ratio?
HLNE's current P/E ratio is 15.8 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is HLNE's RSI?
HLNE's 14-day RSI is 29.28 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is HLNE above its 50-day and 200-day moving averages?
HLNE is 1.27% from its 50-day SMA and -9.44% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is HLNE's next earnings date?
HLNE's next earnings date is currently listed as Nov 3, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does HLNE pay a dividend?
HLNE's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.